Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Ovarian Cancer

SELLAS Life Sciences's Galinpepimut/Opdivo Combo Shows Increased Survival In Mesothelioma Patients

SELLAS Life Sciences Group Inc (NASDAQ:SLS) announced updated data from a Phase 1 clinical trial of galinpepimut-S (GPS), combined with Bristol-Myers Squibb Co's (NYSE:BMY) nivolumab (Opdivo) in with malignant pleural mesothelioma (MPM). The trial included patients who were either refractory or relapsed after at least one line of the standard of care therapy. Data from…

Benzinga

Sajid Javid criticises changes to NHS pages removing word ‘women’

Health secretary says ‘I don’t think it’s right’ after reported amendments to advice pages about ovarian cancer

The Guardian - UK

Sajid Javid: NHS ovarian cancer guidance should use word ‘women’

The Health Secretary said ‘common sense and the right language’ should be used

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Sajid Javid disagrees with NHS ‘removing woman’ from ovarian cancer guidance

Health secretary says he will looking into the wording

The Independent UK

Health Secretary ‘looking into’ ovarian cancer wording on NHS website

Sajid Javid said ‘common sense and the right language’ should be used.

The Independent UK

RBC Says Verastem Interim Analysis In Ovarian Cancer Reinforces Enthusiasm

With the anticipation of a 2Q program update, Verastem Oncology (NASDAQ:VSTM) announced that its interim analysis findings for the RAMP 201 program for recurrent low-grade serous ovarian cancer (LGSOC) continue evaluation in both monotherapy and combination regimens. With incremental updates from ASCO, reiterated KOL enthusiasm, and more updates are upcoming in 2022 on a…

Benzinga

Irish woman, 22, diagnosed with stage three breast cancer after finding small lump

Lauren Barrett said she received her cancer diagnosis at the same time she was told she is a carrier of the BRCA1 gene mutation, which is linked to both breast and ovarian cancer

Irish Mirror

Read news from The Economist, FT, and more,
with one subscription

Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In Pretreated Patients

SELLAS Life Sciences Group Inc (NASDAQ:SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian cancer. The trial evaluated SELLAS' peptide immunotherapeutic combined with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab). Data from 15 patients enrolled in the study has been preliminarily analyzed. Final…

Benzinga

What's Going On With ImmunoGen Shares Today?

ImmunoGen, Inc. (NASDAQ: IMGN) shares are trading flat at $3.57 after the company's Biologics License Application to treat ovarian cancer was accepted by the FDA with priority review.

Benzinga

Ovarian cancer: Four key symptoms that 90 per cent of women are unaware of

Stomach pain, bloating and fatigue are just some of the things to watch out for, especially in those aged 50 and above. Here we detail what you should do if you think you have any symptoms of ovarian cancer.

Daily Mirror

Couple 'traumatised' after being diagnosed with cancer within months of each other

After Paul Boothby, 69, was told he has stage three bowel cancer in August 2021, his partner Diane Boothby, 63, decided to pay for a private scan to get to the root of her symptoms.

Daily Record

Healthy mum chooses to have breasts removed so she can see her sons grow up

Ruth Cookson has a gene mutation that made her more susceptible to breast and ovarian cancer

Wales Online

Tennis legend Chris Evert confirms chemotherapy update after ovarian cancer diagnosis

Tennis legend Chris Evert has provided an update on her chemotherapy after the 18-time grand slam champion revealed she was battling ovarian cancer back in January

Daily Mirror

The signs of ovarian cancer that can often mimic common problems

As ovarian cancer often doesn't produce noticeable symptoms in early stages, and any signs are similar to common problems that are not typically cause for concern, it is possible to have the disease without knowing it for several years

Wales Online

Get all your
news in one place.

100’s of premium titles.
One news app.

Manchester Evening News

Dianne Oxberry's loved ones share ovarian cancer symptoms everyone should know

The beloved BBC weather presenter died within a few months of her diagnosis with the disease

Liverpool Echo

'Red flag' symptoms of ovarian cancer to watch out for

As Sunday marks World Ovarian Cancer Day these are the 'red flag' symptoms to watch out for

Daily Record

Janey Godley overwhelmed after fans help raise £42,000 for Beatson cancer charity

Janey is currently getting treatment for ovarian cancer after being diagnosed in November.

Daily Record

Janey Godley opens up on 'guilt' of not working amid treatment for cancer

The Scots comic was diagnosed with ovarian cancer in November last year after she started suffering symptoms.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Pfizer Injects $25M Via Equity In Zentalis Pharma

Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) will sell 953,834 common shares at $26.21 per share to Pfizer Inc (NYSE:PFE) for $25 million. The offering is expected to close by April 29. Zentalis will use the proceeds to fund ongoing and planned clinical trials, including studies of ZN-c3 and ZN-d5, and for working capital and general corporate…

ABC News

Albury Wodonga Ovarian cancer group calls time on teal undies, fundraising, awareness

After raising $500,000 over 10 years, the Border Ovarian Cancer Awareness Group decides to hang up its teal undies.

Benzinga

U.S. FDA Grants Fast Track designation To Ofra-Vec (VB-111) For Platinum-Resistant Ovarian Cancer

VBL Therapeutics (NASDAQ: VBLT) received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its drug candidate Ofra-Vec (VB-111) in combination with Paclitaxel for the treatment of patients with platinum-resistant ovarian cancer.

Benzinga

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy

Here's a roundup of top developments in the biotech space over the last 24 hours:

The Conversation

Ovarian cancer is not a silent killer – recognizing its symptoms could help reduce misdiagnosis and late detection

Ovarian cancer is the most deadly of gynecologic tumors. Fewer than 40% of those diagnosed with ovarian cancer are cured, and approximately 12,810 people in the U.S. die from the disease every year.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.